Asset and Financial Position of the Bayer Group Statement of Cash Flows (XLS:) Download XLS Bayer Group Summary Statements of Cash Flows Q1 2017 Q1 2018 Change € million € million % 2017 figures restated Net cash provided by (used in) operating activities, continuing operations 551 658 +19.4 Net cash provided by (used in) operating activities, discontinued operations 290 – −100.0 Net cash provided by (used in) operating activities (total) 841 658 −21.8 Net cash provided by (used in) investing activities (total) (1,136) (2,058) −81.2 Net cash provided by (used in) financing activities (total) 611 (581) . Change in cash and cash equivalents due to business activities 316 (1,981) . Cash and cash equivalents at beginning of period 1,899 7,436 . Change due to exchange rate movements and to changes in scope of consolidation 9 (117) . Cash and cash equivalents at end of period 2,224 5,338 +140.0 Net cash provided by operating activities In the first quarter of 2018, the net cash provided by operating activities (total) declined by 21.8% to €658 million. Covestro was still included in the prior-year quarter. The net cash provided by operating activities in continuing operations rose by 19.4% to €658 million due mainly to lower additions to cash tied up in working capital. Net cash used in investing activities Cash outflows for property, plant and equipment and intangible assets were 15.9% lower in the first quarter of 2018 at €349 million (Q1 2017: €415 million), and included €219 million (Q1 2017: €152 million) at Pharmaceuticals, €28 million (Q1 2017: €24 million) at Consumer Health, €63 million (Q1 2017: €99 million) at Crop Science and €5 million (Q1 2017: €6 million) at Animal Health. The prior-year figures included €74 million at Covestro. There was a net cash inflow of €1,802 million from the sale of further Covestro shares. We invested €3,712 million in current financial assets (Q1 2017: €583 million). Net cash used in financing activities In the first quarter of 2018, there was a net cash outflow of €581 million for financing activities, including net loan repayments of €507 million (Q1 2017: €744 million). The prior-year-quarter figure included a net inflow of €1,460 million from the sale of Covestro shares while that company remained fully consolidated. Net interest payments decreased by €31 million to €74 million.